Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Although in most cases the 25-OH-D used for these purposes is produced from vitamin D3, the development of new procedures for the synthesis of the D2 form could be interesting to obtain the corresponding metabolite from non-animal (vegan) sources since ergosterol is industrially produced from yeasts [11].

Source: Background. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Comprehensive assessment of fungal peroxygenases for the selective synthesis of 25-hydroxyvitamins D2 and D3

Study design awaiting verification · Biotechnology for Biofuels and Bioproducts · 2026

Original publication title

Comprehensive assessment of fungal peroxygenases for the selective synthesis of 25-hydroxyvitamins D2 and D3

Alejandro González-Benjumea; Andrés Olmedo; Katharina Ebner; Anton Glieder; Ana Gutiérrez

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This approach represents a green and sustainable alternative to the chemical synthesis of these hydroxylated compounds that is tedious, occurs with little regioselectivity, and includes several steps and strong oxidizing agents. Moreover, K. phaffii a widely used yeast platform for recombinant protein production: including high-yield secretory expression of industrial enzymes: has been firmly established as a favorable host for recombinant UPO production in recent years.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The metabolite 25-hydroxyvitamin D is significantly better for clinical use in several diseases and food supplementations than vitamin D (calciferol) itself. The present study reports an efficient biotechnological method for the synthesis of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3, in one step, starting from the readily available and comparatively inexpensive vitamin D2 (from fungi and yeast) and vitamin D3 (from animals).

Source: Background

Abstract: Results

A widespread investigation of a series of up to 71 unspecific peroxygenases (UPOs), including UPO samples from 41 fungal species (together with several isozymes and variants) expressed in Komagataella phaffii (formerly Pichia pastoris), has been performed for the regioselective C25-hydroxylation of vitamin D (D2 and D3). First experiments revealed that 42 UPOs were able to transform vitamin D2 into its 25-hydroxy derivative within a wide range of conversion rates (from 5% to > 99%), with strict regioselectivity in most cases, determined using GC: MS.

The 16 best UPOs in terms of conversion and regioselectivity were tested for vitamin D3 hydroxylation. With vitamin D3, other hydroxylated derivatives were produced by UPOs in addition to the 25-hydroxy derivative, with the only exception of the UPO from Hypoxylon sp. (HspUPO). Finally, the synthesis of both 25-hydroxyvitamin D2 and D3 was scaled up (up to 20 mM of substrate loading) with HspUPO, using different cosubstrates, such as H2O2 or O2/reductants, with ascorbic acid, gallic acid, or pyrogallol as reductants.

High conversions (68 to 97% for vitamin D2 and 63 to 75% for vitamin D3) and product yields (14 to 19 mM for vitamin D2 and 13 to 15 mM for D3) were attained with all cosubstrates, with pyrogallol/O2 and H2O2 showing the best results with both vitamins.

Source: Results

Abstract: Conclusions

This approach represents a green and sustainable alternative to the chemical synthesis of these hydroxylated compounds that is tedious, occurs with little regioselectivity, and includes several steps and strong oxidizing agents. Moreover, K. phaffii a widely used yeast platform for recombinant protein production: including high-yield secretory expression of industrial enzymes: has been firmly established as a favorable host for recombinant UPO production in recent years.

Source: Conclusions
Authors’ abstract

Background

The metabolite 25-hydroxyvitamin D is significantly better for clinical use in several diseases and food supplementations than vitamin D (calciferol) itself. The present study reports an efficient biotechnological method for the synthesis of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3, in one step, starting from the readily available and comparatively inexpensive vitamin D2 (from fungi and yeast) and vitamin D3 (from animals).

Results

A widespread investigation of a series of up to 71 unspecific peroxygenases (UPOs), including UPO samples from 41 fungal species (together with several isozymes and variants) expressed in Komagataella phaffii (formerly Pichia pastoris), has been performed for the regioselective C25-hydroxylation of vitamin D (D2 and D3). First experiments revealed that 42 UPOs were able to transform vitamin D2 into its 25-hydroxy derivative within a wide range of conversion rates (from 5% to > 99%), with strict regioselectivity in most cases, determined using GC: MS.

The 16 best UPOs in terms of conversion and regioselectivity were tested for vitamin D3 hydroxylation. With vitamin D3, other hydroxylated derivatives were produced by UPOs in addition to the 25-hydroxy derivative, with the only exception of the UPO from Hypoxylon sp. (HspUPO). Finally, the synthesis of both 25-hydroxyvitamin D2 and D3 was scaled up (up to 20 mM of substrate loading) with HspUPO, using different cosubstrates, such as H2O2 or O2/reductants, with ascorbic acid, gallic acid, or pyrogallol as reductants.

High conversions (68 to 97% for vitamin D2 and 63 to 75% for vitamin D3) and product yields (14 to 19 mM for vitamin D2 and 13 to 15 mM for D3) were attained with all cosubstrates, with pyrogallol/O2 and H2O2 showing the best results with both vitamins.

Conclusions

This approach represents a green and sustainable alternative to the chemical synthesis of these hydroxylated compounds that is tedious, occurs with little regioselectivity, and includes several steps and strong oxidizing agents. Moreover, K. phaffii a widely used yeast platform for recombinant protein production: including high-yield secretory expression of industrial enzymes: has been firmly established as a favorable host for recombinant UPO production in recent years.

Graphical Abstract

Figure image at the original source: open the original paper. This file is not included in this text import.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s13068-026-02792-0.

Publication and source details

Original title: Comprehensive assessment of fungal peroxygenases for the selective synthesis of 25-hydroxyvitamins D2 and D3

Alejandro González-Benjumea; Andrés Olmedo; Katharina Ebner; Anton Glieder; Ana Gutiérrez

Biotechnology for Biofuels and Bioproducts · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100000780European CommissionROBUSTOO Project: grant agreement n° 101135119Consejo Superior de Investigaciones Cientificas (CSIC)

Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:08:48.144248+00:00

DOI: 10.1186/s13068-026-02792-0 · PMC13640091